Nearly one in four European pharmaceutical companies remains vulnerable to regulatory risks due to inadequate quality systems ...
The full value of automation is realized only when technology works in concert with the people who guide and interpret it.
It’is increasing the demand for human skills such as judgement, model governance, ethical oversight, and communication ...
For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug ...
The Administrative Adjudication of Road Traffic Offences may be delayed, but the era of “invisible fines” is nearing the end, ...
Many PBMs are also finding their business at risk as pharma–PBM tension continues to intensify. We predict that this tension will continue in 2026, especially for companies with late-stage assets in ...
In the meantime, the big question for data leaders is where to implement this logic. The market has split into two ...
This past Friday, labor economist Guy Berger got to sleep in for the second month in a row. He wasn’t happy about it. The government shutdown meant there was no jobs report from the Bureau of Labor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback